Expecting very active 2026 from a clinical perspective, including significant patient accrual completions and subsequent data readouts from ...

Please reach out to your Barclays representative to schedule a one-on-one meeting. About Alpha Tau Medical Ltd. Founded in 2016, Alpha Tau is an Israeli medical device company that focuses on research ...

Mr. Levy will be available for 1x1 investor meetings. Please reach out to your Jefferies representative to schedule. About Alpha Tau Medical Ltd. Founded in 2016, Alpha Tau is an Israeli oncology ...

The January meeting of the Alpha Tau Chapter of Alpha Delta Kappa International Honorary Organization for Women Educators was ...

- Alpha DaRT pancreatic cancer patient treatments underway in U.S. multi-center pilot study- - Newly received radioactive material license for New Hampshire facility positions the Company for ...

Mr. Levy will be available for 1x1 investor meetings at both conferences. Please reach out to your Piper Sandler and Sidoti representatives to schedule. About Alpha Tau Medical Ltd. Founded in 2016, ...

Alpha Tau Medical Ltd. announced that it has achieved Medical Device Single Audit Program (MDSAP) certification for its manufacturing facility in Jerusalem, which is a key step in ensuring quality, ...

- Interim Jan-2025 results from three trials of Alpha DaRT® in treating pancreatic cancer shared at prestigious 2025 ASCO GI Symposium and R&D Update Day, showing >90% disease control rate, impressive ...

- FDA approval of IDE to conduct a U.S. pilot study exploring the use of Alpha DaRT in patients with recurrent glioblastoma multiforme (GBM), a highly aggressive brain cancer - - Multiple U.S.